Radical Numerics Launches Omnii-1 as First AI-Designed Phage Reaches 1 Human Patient
Updated
Updated · The National Law Review · Oct 20
Radical Numerics Launches Omnii-1 as First AI-Designed Phage Reaches 1 Human Patient
3 articles · Updated · The National Law Review · Oct 20
Summary
Radical Numerics said a phage designed with its new Omnii-1 model was administered to a patient with a persistent drug-resistant bacterial infection under compassionate use access.
Omnii-1 learns across 28 biological data types—including DNA, RNA, proteins and epigenetic signals—letting researchers design a targeted phage within weeks instead of screening candidates for months.
Laboratory testing showed a cocktail containing the AI-designed phage killed the patient's bacterial isolate before treatment, extending earlier August 2026 work on fully AI-created phage genomes into a human case.
The company is also pitching Omnii-1 for biodefense, saying it can flag AI-generated pathogen sequences conventional tools missed and analyze sequencing data within minutes.
How exactly does an AI-designed virus behave inside the human body compared to naturally occurring bacteriophages during a severe infection?
Will the extreme specificity of AI-generated phages make them too expensive and logistically complex to replace standard antibiotics for the general public?
What specific biosecurity safeguards prevent the generative AI used for this breakthrough from being weaponized to create dangerous human pathogens?